Andrey S. Bryukhovetskiy
PhD, MD, Doctor of Medical Science
Date of Birth：August 23, 1959
Place of Birth：USSR, Vladivostok
Degree：Doctor of Medical Sciences
Working experience in regenerative medicine
In 1989 Dr. Andrey Bryukhovetskiy started to apply cell therapy in animal research (calves and dogs) of traumatic spinal cord injury in the Research Institute of Transplantology and Artificial organs under the supervision of the member of the Russian Academy of Sciences Valeriy Shumakov. This experience was described in the monograph Transplantation of neural cells and tissue engineering of the brain and spinal cord (2003). After successful pre-clinical trial of fetal cell therapy for traumatic chronic injury of the brain and spinal cord in 1992, Dr. Bryukhovetskiy was the first in the world who successfully performed intrathecal administration of the suspension of fetal cells to the patient with combat-related injury of the spinal cord. In the same year Dr. Bryukhovetskiy participated in the first transplantation of the sample of nerve tissue to the brain cortex for the case of the mine blast-related injury of the brain. Since 1996 to date Andrey Bryukhovetskiy regularly administered fetal neural cells and stem cells in the cases of the combat injuries of the brain and spinal cord. He is the author and originator of the biodegradable polymer matrix known as SpheroGel© (2000), which is officially approved by the Russian Ministry of Healthcare for tissue engineering of human organs and tissues. Within the framework of the inter-disciplinary research program of the Ministry of Defense, Ministry of Healthcare and Ministry of Internal Affairs of the Russian Federation named Neurotransplantation and Reconstructive-Reparative Transplantation for the Diseases And Injuries of the Central Nervous System and Locomotor System (2000) and branch program of the Russian Academy of Science under the name New Cell Technologies to Medicine, Prof. Bryukhovetskiy performed 8 650 intrathecal transfusions of cell preparations (3302 suspensions of fetal neural cells, 5 558 transfusions of hematopoietic and mesenchymal stem cells). Prof. Bryukhovetskiy participated in 54 surgeries in tissue engineering of the brain and spinal cord that involved transplantations of fetal cells and 52 surgeries in tissue engineering of the spinal cord that involved neural endoprosthetic systems of autologous stem and progenitor cells. This experience is summed in the monograph entitled Spinal cord injury. Cell technologies in the therapy and neurorehabilitation. From 2005 and on Prof. Bryukhovetskliy applies cell technologies in the neurooncology. The results of this research are set in two monographs: Cell technologies in the neurooncology: cyroregulatory therapy of glial tumors of the brain (2001) and Clinical oncoproteomics: proteome-based personalized cell therapy (2013); and the chapters in the edited book Topics in Anticancer research, Volume III (2014). In 2014 another monograph of Prof. Bryukhovetskiy was published under the title The issues of theoretical neurology: information-commutation organization of the brain where a radically new information organization of the brain is described and the stem cells therapy and tissue engineering for neurological diseases are viewed at a novel angle. Prof. Bryukhovetskiy is a vice president in the International Association of Neurorestoratology (IANR).